<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>MMWR Recomm Rep via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'MMWR Recomm Rep' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=MMWR+Recomm+Rep&t=MMWR+Recomm+Rep&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 11:21:08 +0100</lastBuildDate>
        <item>
            <title>Guidelines for field triage of injured patients: recommendations of the national expert panel on field triage, 2011.</title>
            <link>http://www.medworm.com/index.php?rid=5594446&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22237112%26dopt%3DAbstract</link>
            <description>This report describes the dissemination and impact of the 2006 Guidelines; outlines the methodology used by the Panel for its 2011 review; explains the revisions and modifications to the physiologic, anatomic, mechanism-of-injury, and special considerations criteria; updates the schematic of the 2006 Guidelines; and provides the rationale used by the Panel for these changes. This report is intended to help prehospital-care providers in their daily duties recognize individual injured patients who are most likely to benefit from specialized trauma center resources and is not intended as a mass casualty or disaster triage tool. The Panel anticipates a review of these Guidelines approximately every 5 years.
    PMID: 22237112 [PubMed - in process] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5594446</comments>
            <pubDate>Fri, 13 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5594446</guid>        </item>
        <item>
            <title>Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=5575247&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22108587%26dopt%3DAbstract</link>
            <description>This report updates the previously published summary of recommendations for vaccinating health-care personnel (HCP) in the United States (CDC. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices [ACIP] and the Hospital Infection Control Practices Advisory Committee [HICPAC]. MMWR 1997;46[No. RR-18]). This report was reviewed by and includes input from the Healthcare (formerly Hospital) Infection Control Practices Advisory Committee. These updated recommendations can assist hospital administrators, infection-control practitioners, employee health clinicians, and HCP in optimizing infection prevention and control programs. The recommendations for vaccinating HCP are presented by disease in two categories: 1) those diseases for which vaccin...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575247</comments>
            <pubDate>Fri, 25 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575247</guid>        </item>
        <item>
            <title>Immunization of health-care personnel.</title>
            <link>http://www.medworm.com/index.php?rid=5487569&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22108587%26dopt%3DAbstract</link>
            <description>This report updates the previously published summary of recommendations for vaccinating health-care personnel (HCP) in the United States (CDC. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices [ACIP] and the Hospital Infection Control Practices Advisory Committee [HICPAC]. MMWR 1997;46[No. RR-18]). This report was reviewed by and includes input from the Healthcare (formerly Hospital) Infection Control Practices Advisory Committee. These updated recommendations can assist hospital administrators, infection-control practitioners, employee health clinicians, and HCP in optimizing infection prevention and control programs. The recommendations for vaccinating HCP are presented by disease in two categories: 1) those diseases for which vaccin...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5487569</comments>
            <pubDate>Fri, 25 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5487569</guid>        </item>
        <item>
            <title>Compendium of animal rabies prevention and control, 2011.</title>
            <link>http://www.medworm.com/index.php?rid=5409330&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22052042%26dopt%3DAbstract</link>
            <description>This report provides recommendations for public health officials, veterinarians, animal control officials, and other parties engaged in rabies prevention and control activities and should serve as the basis for standardizing procedures among jurisdictions. The recommendations regarding domestic animal vaccination, management of animals exposed to rabies, and management of animals that bite humans are the core elements of animal rabies control and human rabies prevention. These updated 2011 guidelines include the national case definition for animal rabies and clarify the role of the CDC rabies laboratory in providing confirmatory testing of suspect animals. The table of rabies vaccines licensed and marketed in the United States has been updated, and additional references have been included ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409330</comments>
            <pubDate>Fri, 04 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5409330</guid>        </item>
        <item>
            <title>School health guidelines to promote healthy eating and physical activity.</title>
            <link>http://www.medworm.com/index.php?rid=5224458&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21918496%26dopt%3DAbstract</link>
            <description>This report describes school health guidelines for promoting healthy eating and physical activity, including coordination of school policies and practices; supportive environments; school nutrition services; physical education and physical activity programs; health education; health, mental health, and social services; family and community involvement; school employee wellness; and professional development for school staff members. These guidelines, developed in collaboration with specialists from universities and from national, federal, state, local, and voluntary agencies and organizations, are based on an in-depth review of research, theory, and best practices in healthy eating and physical activity promotion in school health, public health, and education. Because every guideline might ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5224458</comments>
            <pubDate>Fri, 16 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5224458</guid>        </item>
        <item>
            <title>Compendium of measures to prevent disease associated with animals in public settings, 2011: national association of state public health veterinarians, inc.</title>
            <link>http://www.medworm.com/index.php?rid=4795517&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21546893%26dopt%3DAbstract</link>
            <description>This report provides recommendations for public health officials, veterinarians, animal venue staff members, animal exhibitors, visitors to animal venues, physicians, and others concerned with minimizing risks associated with animals in public settings. The recommendation to wash hands is the most important for reducing the risk for disease transmission associated with animals in public settings. Other important recommendations are that venues prohibit food in animal areas and include transition areas between animal areas and nonanimal areas, visitors receive information about disease risk and prevention procedures, and animals be properly cared for and managed. These updated 2011 guidelines provide new information on the risks associated with amphibians and with animals in day camp settin...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4795517</comments>
            <pubDate>Thu, 05 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4795517</guid>        </item>
        <item>
            <title>Updated norovirus outbreak management and disease prevention guidelines.</title>
            <link>http://www.medworm.com/index.php?rid=4567034&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21368741%26dopt%3DAbstract</link>
            <description>This report reviews these recent advances and provides guidelines for outbreak management and disease prevention. These recommendations are intended for use by public health professionals investigating outbreaks of acute gastroenteritis, including state and local health authorities, as well as academic and research institutions.
    PMID: 21368741 [PubMed - in process] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4567034</comments>
            <pubDate>Fri, 04 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4567034</guid>        </item>
        <item>
            <title>Sexually transmitted diseases treatment guidelines, 2010.</title>
            <link>http://www.medworm.com/index.php?rid=4267015&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21160459%26dopt%3DAbstract</link>
            <description>Authors:  
    These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18--30, 2009. The information in this report updates the 2006 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 2006;55[No. RR--11]). Included in these updated guidelines is new information regarding 1) the expanded diagnostic evaluation for cervicitis and trichomoniasis; 2) new treatment recommendations for bacterial vaginosis and genital warts; 3) the clinical efficacy of azithromycin for chlamydial infections in pregnancy; 4) the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-rel...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4267015</comments>
            <pubDate>Fri, 17 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4267015</guid>        </item>
        <item>
            <title>Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine -- Recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=4267020&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21150868%26dopt%3DAbstract</link>
            <description>This report summarizes recommendations approved by the Advisory Committee on Immunization Practices (ACIP) on February 24, 2010, for the use of PCV13 to prevent pneumococcal disease in infants and young children aged &amp;lt;6 years. Recommendations include 1) routine vaccination of all children aged 2-59 months, 2) vaccination of children aged 60-71 months with underlying medical conditions, and 3) vaccination of children who received ≥1 dose of PCV7 previously (CDC. Licensure of a 13-valent pneumococcal conjugate vaccine [PCV13] and recommendations for use among children-Advisory Committee on Immunization Practices [ACIP], 2010. MMWR 2010;59:258-61). Recommendations also are provided for targeted use of the 23-valent pneumococcal polysaccharide vaccine (PPSV23, formerly PPV23) in children ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4267020</comments>
            <pubDate>Fri, 10 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4267020</guid>        </item>
        <item>
            <title>Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.</title>
            <link>http://www.medworm.com/index.php?rid=4267024&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21088663%26dopt%3DAbstract</link>
            <description>This report presents CDC's updated guidelines, which have been endorsed by the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics, the American College of Nurse-Midwives, the American Academy of Family Physicians, and the American Society for Microbiology. The recommendations were made on the basis of available evidence when such evidence was sufficient and on expert opinion when available evidence was insufficient. The key changes in the 2010 guidelines include the following: • expanded recommendations on laboratory methods for the identification of GBS, • clarification of the colony-count threshold required for reporting GBS detected in the urine of pregnant women, • updated algorithms for GBS screening and intrapartum chemoprophylaxis for women...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4267024</comments>
            <pubDate>Fri, 19 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4267024</guid>        </item>
        <item>
            <title>Prevention of Perinatal Group B Streptococcal Disease -- Revised Guidelines from CDC, 2010.</title>
            <link>http://www.medworm.com/index.php?rid=4197572&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21088663%26dopt%3DAbstract</link>
            <description>This report presents CDC's updated guidelines, which have been endorsed by the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics, the American College of Nurse-Midwives, the American Academy of Family Physicians, and the American Society for Microbiology. The recommendations were made on the basis of available evidence when such evidence was sufficient and on expert opinion when available evidence was insufficient. The key changes in the 2010 guidelines include the following: • expanded recommendations on laboratory methods for the identification of GBS, • clarification of the colony-count threshold required for reporting GBS detected in the urine of pregnant women, • updated algorithms for GBS screening and intrapartum chemoprophylaxis for women...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4197572</comments>
            <pubDate>Fri, 19 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4197572</guid>        </item>
        <item>
            <title>Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=4024513&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20829749%26dopt%3DAbstract</link>
            <description>Authors: Grummer-Strawn LM, Reinold C, Krebs NF, 
    In April 2006, the World Health Organization (WHO) released new international growth charts for children aged 0-59 months. Similar to the 2000 CDC growth charts, these charts describe weight for age, length (or stature) for age, weight for length (or stature), and body mass index for age. Whereas the WHO charts are growth standards, describing the growth of healthy children in optimal conditions, the CDC charts are a growth reference, describing how certain children grew in a particular place and time. However, in practice, clinicians use growth charts as standards rather than references. In 2006, CDC, the National Institutes of Health, and the American Academy of Pediatrics convened an expert panel to review scientific evidence and dis...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4024513</comments>
            <pubDate>Thu, 09 Sep 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4024513</guid>        </item>
        <item>
            <title>Use of World Health Organization and CDC Growth Charts for Children Aged 0--59 Months in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=3960748&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20829749%26dopt%3DAbstract</link>
            <description>Authors:  
    In April 2006, the World Health Organization (WHO) released new international growth charts for children aged 0--59 months. Similar to the 2000 CDC growth charts, these charts describe weight for age, length (or stature) for age, weight for length (or stature), and body mass index for age. Whereas the WHO charts are growth standards, describing the growth of healthy children in optimal conditions, the CDC charts are a growth reference, describing how certain children grew in a particular place and time. However, in practice, clinicians use growth charts as standards rather than references. In 2006, CDC, the National Institutes of Health, and the American Academy of Pediatrics convened an expert panel to review scientific evidence and discuss the potential use of the new WHO ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3960748</comments>
            <pubDate>Thu, 09 Sep 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3960748</guid>        </item>
        <item>
            <title>Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.</title>
            <link>http://www.medworm.com/index.php?rid=3832386&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20689501%26dopt%3DAbstract</link>
            <description>This report updates the 2009 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2009;58[No. RR-8] and CDC. Use of influenza A (H1N1) 2009 monovalent vaccine---recommendations of the Advisory Committee on Immunization Practices [ACIP], 2009. MMWR 2009;58:[No. RR-10]). The 2010 influenza recommendations include new and updated information. Highlights of the 2010 recommendations include 1) a recommendation that annual vaccination be administered to all persons aged &amp;gt;/=6 months for the 2010--11 influenza season; 2) a recommendation that children aged 6 months--8...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3832386</comments>
            <pubDate>Thu, 05 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3832386</guid>        </item>
        <item>
            <title>Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=3808907&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20671663%26dopt%3DAbstract</link>
            <description>This report updates CDC's recommendations for using yellow fever (YF) vaccine (CDC. Yellow fever vaccine: recommendations of the Advisory Committee on Immunizations Practices: MMWR 2002;51[No. RR-17]). Since the previous YF vaccine recommendations were published in 2002, new or additional information has become available on the epidemiology of YF, safety profile of the vaccine, and health regulations related to the vaccine. This report summarizes the current epidemiology of YF, describes immunogenicity and safety data for the YF vaccine, and provides recommendations for the use of YF vaccine among travelers and laboratory workers. YF is a vectorborne disease resulting from the transmission of yellow fever virus (YFV) to a human from the bite of an infected mosquito. It is endemic to sub-Sa...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3808907</comments>
            <pubDate>Thu, 29 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3808907</guid>        </item>
        <item>
            <title>Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.</title>
            <link>http://www.medworm.com/index.php?rid=3784844&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20651644%26dopt%3DAbstract</link>
            <description>Authors:  
    These recommendations from the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations for anthrax vaccine adsorbed (AVA) (CDC. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2000;49:1--20; CDC. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2002;51:1024--6) and reflect the status of anthrax vaccine supplies in the United States. This statement 1) provides updated information on anthrax epidemiology; 2) summarizes the evidence regarding the effectiveness and efficacy, immunogenicity, and safety of AVA; 3) provides recommendations for pre-event and preexposure use of AVA; ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3784844</comments>
            <pubDate>Thu, 22 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3784844</guid>        </item>
        <item>
            <title>Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.</title>
            <link>http://www.medworm.com/index.php?rid=3718993&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20577159%26dopt%3DAbstract</link>
            <description>This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Multiple additional recommendations are provided that address quality control, test selection, and medical management after testing. Although substantial progress has been made in documenting the utility of IGRAs, additional research is needed that focuses on the value and limitations of IGRAs in situations of importance to medical care or tuberculosis control. Specific ar...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3718993</comments>
            <pubDate>Thu, 24 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3718993</guid>        </item>
        <item>
            <title>Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection --- United States, 2010.</title>
            <link>http://www.medworm.com/index.php?rid=3700145&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20577159%26dopt%3DAbstract</link>
            <description>This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Multiple additional recommendations are provided that address quality control, test selection, and medical management after testing. Although substantial progress has been made in documenting the utility of IGRAs, additional research is needed that focuses on the value and limitations of IGRAs in situations of importance to medical care or tuberculosis control. Specific ar...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3700145</comments>
            <pubDate>Thu, 24 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3700145</guid>        </item>
        <item>
            <title>U S. Medical Eligibility Criteria for Contraceptive Use, 2010: Adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition.</title>
            <link>http://www.medworm.com/index.php?rid=3679954&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20559203%26dopt%3DAbstract</link>
            <description>Authors:  
    CDC created U.S. Medical Eligibility Criteria for Contraceptive Use, 2010, from guidance developed by the World Health Organization (WHO) and finalized the recommendations after consultation with a group of health professionals who met in Atlanta, Georgia, during February 2009. This guidance comprises recommendations for the use of specific contraceptive methods by women and men who have certain characteristics or medical conditions. The majority of the U.S. guidance does not differ from the WHO guidance and covers &amp;gt;60 characteristics or medical conditions. However, some WHO recommendations were modified for use in the United States, including recommendations about contraceptive use for women with venous thromboembolism, valvular heart disease, ovarian cancer, and uterine...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3679954</comments>
            <pubDate>Thu, 17 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3679954</guid>        </item>
        <item>
            <title>Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=3545604&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20448530%26dopt%3DAbstract</link>
            <description>This report presents new recommendations adopted in June 2009 by CDC's Advisory Committee on Immunization Practices (ACIP) regarding use of the combination measles, mumps, rubella, and varicella vaccine (MMRV, ProQuad, Merck &amp; Co., Inc.). MMRV vaccine was licensed in the United States in September 2005 and may be used instead of measles, mumps, rubella vaccine (MMR, M-M-RII, Merck &amp; Co., Inc.) and varicella vaccine (VARIVAX, Merck &amp; Co., Inc.) to implement the recommended 2-dose vaccine schedule for prevention of measles, mumps, rubella, and varicella among children aged 12 months-12 years. At the time of its licensure, use of MMRV vaccine was preferred for both the first and second doses over separate injections of equivalent component vaccines (MMR vaccine and varicella vacci...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3545604</comments>
            <pubDate>Thu, 06 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3545604</guid>        </item>
        <item>
            <title>Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.</title>
            <link>http://www.medworm.com/index.php?rid=3385732&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20300058%26dopt%3DAbstract</link>
            <description>This report summarizes new recommendation and updates previous recommendations of the Advisory Committee on Immunization Practices (ACIP) for postexposure prophylaxis (PEP) to prevent human rabies (CDC. Human rabies prevention---United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR 2008;57[No. RR-3]). Previously, ACIP recommended a 5-dose rabies vaccination regimen with human diploid cell vaccine (HDCV) or purified chick embryo cell vaccine (PCECV). These new recommendations reduce the number of vaccine doses to four. The reduction in doses recommended for PEP was based in part on evidence from rabies virus pathogenesis data, experimental animal work, clinical studies, and epidemiologic surveillance. These studies indicated that 4 vaccine doses in c...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3385732</comments>
            <pubDate>Fri, 19 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3385732</guid>        </item>
        <item>
            <title>Japanese Encephalitis Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=3359973&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20224546%26dopt%3DAbstract</link>
            <description>This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC. Inactivated Japanese encephalitis virus vaccine: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 1993;42[No. RR-1]). This report summarizes the epidemiology of JE, describes the two JE vaccines that are licensed in the United States, and provides recommendations for their use among travelers and laboratory workers. JE virus (JEV), a mosquito-borne flavivirus, is the most common vaccine-preventable cause of encephalitis in Asia. JE occurs throughout most of Asia and parts of the western Pacific. Among an estimated 35,000--50,000 annual cases, 20%--30% of patients die, and 30%--5...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3359973</comments>
            <pubDate>Fri, 12 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3359973</guid>        </item>
        <item>
            <title>Recommendations for Diagnosis of Shiga Toxin--Producing Escherichia coli Infections by Clinical Laboratories.</title>
            <link>http://www.medworm.com/index.php?rid=2901882&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19834454%26dopt%3DAbstract</link>
            <description>This report provides comprehensive and detailed recommendations for STEC testing by clinical laboratories, including the recommendation that all stools submitted for routine testing from patients with acute community-acquired diarrhea (regardless of patient age, season of the year, or presence or absence of blood in the stool) be simultaneously cultured for E. coli O157:H7 (O157 STEC) and tested with an assay that detects Shiga toxins to detect non-O157 STEC. The report also includes detailed procedures for specimen selection, handling, and transport; a review of culture and nonculture tests for STEC detection; and clinical considerations and recommendations for management of patients with STEC infection. Improving the diagnostic accuracy of STEC infection by clinical laboratories should e...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2901882</comments>
            <pubDate>Thu, 15 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2901882</guid>        </item>
        <item>
            <title>Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.</title>
            <link>http://www.medworm.com/index.php?rid=2770381&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19730409%26dopt%3DAbstract</link>
            <description>This report updates and combines into one document earlier versions of guidelines for preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected children, last published in 2002 and 2004, respectively. These guidelines are intended for use by clinicians and other health-care workers providing medical care for HIV-exposed and HIV-infected children in the United States. The guidelines discuss opportunistic pathogens that occur in the United States and one that might be acquired during international travel (i.e., malaria). Topic areas covered for each OI include a brief description of the epidemiology, clinical presentation, and diagnosis of the OI in children; prevention of exposure; prevention of disease by chemoprophylaxis and/or vaccination; discontinuation ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2770381</comments>
            <pubDate>Thu, 03 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2770381</guid>        </item>
        <item>
            <title>Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.</title>
            <link>http://www.medworm.com/index.php?rid=2745668&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19713882%26dopt%3DAbstract</link>
            <description>This report provides recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of vaccine against infection with novel influenza A (H1N1) virus. Information on vaccination for seasonal influenza has been published previously (CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices [ACIP], 2009. MMWR 2009;58[No. RR-8]). Vaccines against novel influenza A (H1N1) virus infection have not yet been licensed; however, licensed vaccine is expected to be available by mid-October 2009. On July 29, 2009, ACIP reviewed epidemiologic and clinical data to determine which population groups should be targeted initially for vaccination. ACIP also considered the projected vaccine supply likely ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2745668</comments>
            <pubDate>Thu, 27 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2745668</guid>        </item>
        <item>
            <title>Recommendations for blood lead screening of medicaid-eligible children aged 1-5 years: an updated approach to targeting a group at high risk.</title>
            <link>http://www.medworm.com/index.php?rid=2682169&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19661858%26dopt%3DAbstract</link>
            <description>This report presents the updated CDC recommendations and provides strategies to 1) improve screening rates of children at risk for EBLLs, 2) develop surveillance strategies that are not solely dependent on BLL testing, and 3) assist states with evaluation of screening plans.
    PMID: 19661858 [PubMed - in process] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2682169</comments>
            <pubDate>Thu, 06 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2682169</guid>        </item>
        <item>
            <title>Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.</title>
            <link>http://www.medworm.com/index.php?rid=2662836&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19644442%26dopt%3DAbstract</link>
            <description>This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2008;57[No. RR-7]). Information on vaccination issues related to the recently identified novel influenza A H1N1 virus will be published later in 2009. The 2009 seasonal influenza recommendations include new and updated information. Highlights of the 2009 recommendations include 1) a recommendation that annual vaccination be administered to all children aged 6 months-18 years for the 2009-10 influenza season; 2) a recommendation that vaccines containing the 2009-10 trivalent...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2662836</comments>
            <pubDate>Thu, 30 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2662836</guid>        </item>
        <item>
            <title>Recommended community strategies and measurements to prevent obesity in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=2639812&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19629029%26dopt%3DAbstract</link>
            <description>This report describes the expert panel process that was used to identify 24 recommended strategies for obesity prevention and a suggested measurement for each strategy that communities can use to assess performance and track progress over time. The 24 strategies are divided into six categories: 1) strategies to promote the availability of affordable healthy food and beverages), 2) strategies to support healthy food and beverage choices, 3) a strategy to encourage breastfeeding, 4) strategies to encourage physical activity or limit sedentary activity among children and youth, 5) strategies to create safe communities that support physical activity, and 6) a strategy to encourage communities to organize for change.
    PMID: 19629029 [PubMed - in process] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2639812</comments>
            <pubDate>Thu, 23 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2639812</guid>        </item>
        <item>
            <title>Good laboratory practices for molecular genetic testing for heritable diseases and conditions.</title>
            <link>http://www.medworm.com/index.php?rid=2544602&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19521335%26dopt%3DAbstract</link>
            <description>This report provides CLIAC recommendations for good laboratory practices for ensuring the quality of molecular genetic testing for heritable diseases and conditions. The recommended practices address the total testing process (including the preanalytic,analytic,and postanalytic phases),laboratory responsibilities regarding authorized persons,confidentiality of patient information,personnel competency,considerations before introducing molecular genetic testing or offering new molecular genetic tests,and the quality management system approach to molecular genetic testing. These recommendations are intended for laboratories that perform molecular genetic testing for heritable diseases and conditions and for medical and public health professionals who evaluate laboratory practices and policies...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2544602</comments>
            <pubDate>Thu, 11 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2544602</guid>        </item>
        <item>
            <title>Compendium of measures to prevent disease associated with animals in public settings, 2009: National Association of State Public Health Veterinarians, Inc. (NASPHV).</title>
            <link>http://www.medworm.com/index.php?rid=2544603&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19407740%26dopt%3DAbstract</link>
            <description>This report provides recommendations for public health officials, veterinarians, animal venue staff members, animal exhibitors, visitors to animal venues, physicians, and others concerned with minimizing risks associated with animals in public settings. The recommendation to wash hands is the most important prevention step for reducing the risk for disease transmission associated with animals in public settings. Other critical recommendations are that venues prohibit food in animal areas, venues include transition areas between animal areas and nonanimal areas, visitors receive information about disease risk and prevention procedures, and animals be properly cared for and managed. These updated 2009 guidelines also emphasize risks associated with baby poultry, reptiles, and rodents in publ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2544603</comments>
            <pubDate>Thu, 30 Apr 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2544603</guid>        </item>
        <item>
            <title>Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.</title>
            <link>http://www.medworm.com/index.php?rid=2322233&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19357635%26dopt%3DAbstract</link>
            <description>This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs) in HIV-infected adults (i.e., persons aged &amp;gt;/=18 years) and adolescents (i.e., persons aged 13--17 years), last published in 2002 and 2004, respectively. It has been prepared by the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by clinicians and other health-care providers, HIV-infected patients, and policy makers in the United States. These guidelines address several OIs that occur in the United States and five OIs that might be acquired during international travel. Topic areas covere...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2322233</comments>
            <pubDate>Fri, 10 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2322233</guid>        </item>
        <item>
            <title>Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.</title>
            <link>http://www.medworm.com/index.php?rid=2198663&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19214162%26dopt%3DAbstract</link>
            <description>Authors:  
    An estimated one third of the world's population is infected with Mycobacterium tuberculosis, and nearly 9 million persons develop disease caused by M. tuberculosis each year. Although tuberculosis (TB) occurs predominantly in resource-limited countries, it also occurs in the United States. During 1985-1992, the United States was confronted with an unprecedented TB resurgence. This resurgence was accompanied by a rise in multidrug-resistant TB (MDR TB), which is defined as TB that is resistant to the two most effective first-line therapeutic drugs, isoniazid and rifampin. In addition, virtually untreatable strains of M. tuberculosis are emerging globally. Extensively drug-resistant (XDR) TB is defined as MDR TB that also is resistant to the most effective second-line therape...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2198663</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2198663</guid>        </item>
        <item>
            <title>Plan to combat extensively drug-resistant tuberculosis recommendations of the federal tuberculosis task force.</title>
            <link>http://www.medworm.com/index.php?rid=2186331&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19214162%26dopt%3DAbstract</link>
            <description>Authors: Lobue P, Sizemore C, Castro KG, 
    An estimated one third of the world's population is infected with Mycobacterium tuberculosis, and nearly 9 million persons develop disease caused by M. tuberculosis each year. Although tuberculosis (TB) occurs predominantly in resource-limited countries, it also occurs in the United States. During 1985--1992, the United States was confronted with an unprecedented TB resurgence. This resurgence was accompanied by a rise in multidrug-resistant TB (MDR TB), which is defined as TB that is resistant to the two most effective first-line therapeutic drugs, isoniazid and rifampin. In addition, virtually untreatable strains of M. tuberculosis are emerging globally. Extensively drug-resistant (XDR) TB is defined as MDR TB that also is resistant to the mo...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186331</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186331</guid>        </item>
        <item>
            <title>Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=2166508&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19194371%26dopt%3DAbstract</link>
            <description>This report updates and replaces the 2006 ACIP statement for prevention of rotavirus gastroenteritis. ACIP recommends routine vaccination of U.S. infants with rotavirus vaccine. RV5 and RV1 differ in composition and schedule of administration. RV5 is to be administered orally in a 3-dose series, with doses administered at ages 2, 4, and 6 months. RV1 is to be administered orally in a 2-dose series, with doses administered at ages 2 and 4 months. ACIP does not express a preference for either RV5 or RV1. The recommendations in this report also address the maximum ages for doses, contraindications, precautions, and special situations for the administration of rotavirus vaccine.
    PMID: 19194371 [PubMed - indexed for MEDLINE] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2166508</comments>
            <pubDate>Fri, 06 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2166508</guid>        </item>
        <item>
            <title>Guidelines for field triage of injured patients. Recommendations of the National Expert Panel on Field Triage.</title>
            <link>http://www.medworm.com/index.php?rid=2133893&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19165138%26dopt%3DAbstract</link>
            <description>This report describes the process and rationale used by the Expert Panel to revise the Decision Scheme.
    PMID: 19165138 [PubMed - indexed for MEDLINE] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2133893</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2133893</guid>        </item>
        <item>
            <title>Guidelines for Field Triage of Injured Patients Recommendations of the National Expert Panel on Field Triage.</title>
            <link>http://www.medworm.com/index.php?rid=2130649&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19165138%26dopt%3DAbstract</link>
            <description>This report describes the process and rationale used by the Expert Panel to revise the Decision Scheme.
    PMID: 19165138 [PubMed - as supplied by publisher] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2130649</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2130649</guid>        </item>
        <item>
            <title>Revised Surveillance Case Definitions for HIV Infection Among Adults, Adolescents, and Children Aged</title>
            <link>http://www.medworm.com/index.php?rid=2015663&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19052530%26dopt%3DAbstract</link>
            <description>Authors: Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT, 
    For adults and adolescents (i.e., persons aged &amp;gt;/=13 years), the human immunodeficiency virus (HIV) infection classification system and the surveillance case definitions for HIV infection and acquired immunodeficiency syndrome (AIDS) have been revised and combined into a single case definition for HIV infection. In addition, the HIV infection case definition for children aged &amp;lt;13 years and the AIDS case definition for children aged 18 months to &amp;lt;13 years have been revised. No changes have been made to the HIV infection classification system, the 24 AIDS-defining conditions for children aged &amp;lt;13 years, or the AIDS case definition for children aged &amp;lt;18 months. These case definitions are intende...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2015663</comments>
            <pubDate>Fri, 05 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2015663</guid>        </item>
        <item>
            <title>Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection.</title>
            <link>http://www.medworm.com/index.php?rid=1942350&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18987617%26dopt%3DAbstract</link>
            <description>This report provides updated, integrated recommendations for services provided to partners of persons with human immunodeficiency virus (HIV) infection and three other sexually transmitted diseases (STDs) (i.e., syphilis, gonorrhea, and chlamydial infection) and replaces the CDC 2001 Program Operations Guidelines for STD Prevention---Partner Services and the 1998 HIV Partner Counseling and Referral Services Guidance. These recommendations are intended for health department program managers responsible for overseeing partner services programs for HIV infection and the three other STDs at the state and local levels. The recommendations also might be beneficial for HIV prevention community planning groups, STD program advisory bodies, technical assistance providers, community-based organizati...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1942350</comments>
            <pubDate>Fri, 07 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1942350</guid>        </item>
        <item>
            <title>Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.</title>
            <link>http://www.medworm.com/index.php?rid=1810883&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18802412%26dopt%3DAbstract</link>
            <description>This report updates and expands previous CDC guidelines for HBsAg testing and includes new recommendations for public health evaluation and management for chronically infected persons and their contacts. Routine testing for HBsAg now is recommended for additional populations with HBsAg prevalence of &amp;gt;/=2%: persons born in geographic regions with HBsAg prevalence of &amp;gt;/=2%, men who have sex with men, and injection-drug users. Implementation of these recommendations will require expertise and resources to integrate HBsAg screening in prevention and care settings serving populations recommended for HBsAg testing. This report is intended to serve as a resource for public health officials, organizations, and health-care professionals involved in the development, delivery, and evaluation of...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1810883</comments>
            <pubDate>Fri, 19 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1810883</guid>        </item>
        <item>
            <title>Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.</title>
            <link>http://www.medworm.com/index.php?rid=1691189&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18685555%26dopt%3DAbstract</link>
            <description>This report updates the 2007 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2007;56[No. RR-6]). The 2008 recommendations include new and updated information. Principal updates and changes include 1) a new recommendation that annual vaccination be administered to all children aged 5--18 years, beginning in the 2008--09 influenza season, if feasible, but no later than the 2009--10 influenza season; 2) a recommendation that annual vaccination of all children aged 6 months through 4 years (59 months) continue to be a primary focus of vaccination efforts because these children are at ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1691189</comments>
            <pubDate>Fri, 08 Aug 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1691189</guid>        </item>
        <item>
            <title>Recommendations for postexposure interventions to prevent infection with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus, and tetanus in persons wounded during bombings and other mass-casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention (CDC).</title>
            <link>http://www.medworm.com/index.php?rid=1673868&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18668022%26dopt%3DAbstract</link>
            <description>This report outlines recommendations for postexposure interventions to prevent infection with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus, and tetanus in persons wounded during bombings or other events resulting in mass casualties. Persons wounded during such events or in conjunction with the resulting emergency response might be exposed to blood, body fluids, or tissue from other injured persons and thus be at risk for bloodborne infections. This report adapts existing general recommendations on the use of immunization and postexposure prophylaxis for tetanus and for occupational and nonoccupational exposures to bloodborne pathogens to the specific situation of a mass-casualty event. Decisions regarding the implementation of prophylaxis are complex, and drawing p...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1673868</comments>
            <pubDate>Fri, 01 Aug 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1673868</guid>        </item>
        <item>
            <title>Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=1496162&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18528318%26dopt%3DAbstract</link>
            <description>This report summarizes the epidemiology of zoster and its sequelae, describes the zoster vaccine, and provides recommendations for its use among adults aged &amp;gt;/=60 years in the United States. Zoster is a localized, generally painful cutaneous eruption that occurs most frequently among older adults and immunocompromised persons. It is caused by reactivation of latent varicella zoster virus (VZV) decades after initial VZV infection is established. Approximately one in three persons will develop zoster during their lifetime, resulting in an estimated 1 million episodes in the United States annually. A common complication of zoster is postherpetic neuralgia (PHN), a chronic, often debilitating pain condition that can last months or even years. The risk for PHN in patients with zoster is 10%-...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1496162</comments>
            <pubDate>Fri, 06 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1496162</guid>        </item>
        <item>
            <title>Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=1479618&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18509304%26dopt%3DAbstract</link>
            <description>This report 1) describes the clinical features of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants, 2) reviews available evidence of pertussis vaccination during pregnancy as a strategy to prevent infant pertussis, 3) summarizes Tdap vaccination policy in the United States, and 4) presents recommendations for use of Td and Tdap vaccines among pregnant and postpartum women.
    PMID: 18509304 [PubMed - in process] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1479618</comments>
            <pubDate>Fri, 30 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1479618</guid>        </item>
        <item>
            <title>Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.</title>
            <link>http://www.medworm.com/index.php?rid=1462876&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18496505%26dopt%3DAbstract</link>
            <description>Authors: Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, Sun B, Hull HF, 
    These recommendations of the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations on human rabies prevention (CDC. Human rabies prevention--United States, 1999: recommendations of the Advisory Committee on Immunization Practices. MMWR 1999;48 [No. RR-1]) and reflect the status of rabies and antirabies biologics in the United States. This statement 1) provides updated information on human and animal rabies epidemiology; 2) summarizes the evidence regarding the effectiveness/efficacy, immunogenicity, and safety of rabies biologics; 3) presents new information on the cost-effectiveness of rabies postexposure ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1462876</comments>
            <pubDate>Fri, 23 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1462876</guid>        </item>
        <item>
            <title>Compendium of animal rabies prevention and control, 2008: National Association of State Public Health Veterinarians, Inc. (NASPHV).</title>
            <link>http://www.medworm.com/index.php?rid=1381755&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18418348%26dopt%3DAbstract</link>
            <description>Authors:  
    Rabies is a fatal viral zoonosis and a serious public health problem. The disease is an acute, progressive encephalitis caused by a lyssavirus. Although the United States has been declared free of canine rabies virus variant transmission, multiple viral variants are maintained in wild mammal populations, and there is always a risk of reintroduction of canine rabies. All mammals are believed to be susceptible to the disease, and for purposes of this document, use of the term &quot;animal&quot; refers to mammals. The recommendations in this compendium serve as a basis for animal rabies-prevention and -control programs throughout the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an effective national rabies-control program. This d...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1381755</comments>
            <pubDate>Fri, 18 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1381755</guid>        </item>
        <item>
            <title>Strategies to improve external cause-of-injury coding in state-based hospital discharge and emergency department data systems: recommendations of the CDC Workgroup for Improvement of External Cause-of-Injury Coding.</title>
            <link>http://www.medworm.com/index.php?rid=1333937&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18368008%26dopt%3DAbstract</link>
            <description>This report discusses the value of using high-quality Ecoding to collect data in state-based morbidity data systems. Recommendations are provided to improve communication regarding Ecoding among stakeholders, enhance the completeness and accuracy of Ecoding, and make Ecoded data more useful for injury surveillance and prevention activities at the local, state, and federal levels. Implementing the recommendations outlined in this report should result in substantial improvements in the quality of external cause-of-injury data collected in hospital discharge and ED data systems in the United States and its territories.
    PMID: 18368008 [PubMed - in process] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1333937</comments>
            <pubDate>Fri, 28 Mar 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1333937</guid>        </item>
        <item>
            <title>Effects on violence of laws and policies facilitating the transfer of youth from the juvenile to the adult justice system: a report on recommendations of the Task Force on Community Preventive Services.</title>
            <link>http://www.medworm.com/index.php?rid=1062100&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18046302%26dopt%3DAbstract</link>
            <description>Authors: Hahn R, McGowan A, Liberman A, Crosby A, Fullilove M, Johnson R, Moscicki E, Price L, Snyder S, Tuma F, Lowy J, Briss P, Cory S, Stone G, 
    The independent, nonfederal Task Force on Community Preventive Services (Task Force), which directs the development of the Guide to Community Preventive Services (Community Guide), conducted a systematic review of published scientific evidence concerning the effectiveness of laws and policies that facilitate the transfer of juveniles to the adult criminal justice system to determine whether these transfers prevent or reduce violence among youth who have been transferred and among the juvenile population as a whole. For this review, transfer is defined as placing juveniles aged &amp;lt;18 years under the jurisdiction of the adult criminal justic...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1062100</comments>
            <pubDate>Fri, 30 Nov 2007 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1062100</guid>        </item>
        <item>
            <title>Interpreting and Managing Blood Lead Levels</title>
            <link>http://www.medworm.com/index.php?rid=1002064&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17975528%26dopt%3DAbstract</link>
            <description>This report summarizes the findings of a review of clinical interpretation and management of BLLs &amp;lt;/=10 mug/dL conducted by CDC's Advisory Committee on Childhood Lead Poisoning Prevention. This report provides information to help clinicians understand BLLs &amp;lt;/=10 mug/dL, identifies gaps in knowledge concerning lead levels in this range, and outlines strategies to reduce childhood exposures to lead. In addition, this report summarizes scientific data relevant to counseling, blood lead screening, and lead exposure risk assessment. To aid in the interpretation of BLLs, clinicians should understand the laboratory error range for blood lead values and, if possible, select a laboratory that achieves routine performance within +/-2 mug/dL. Clinicians should obtain an environmental history on...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1002064</comments>
            <pubDate>Fri, 02 Nov 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1002064</guid>        </item>
        <item>
            <title>The effectiveness of universal school-based programs for the prevention of violent and aggressive behavior: a report on recommendations of the Task Force on Community Preventive Services.</title>
            <link>http://www.medworm.com/index.php?rid=792183&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17687245%26dopt%3DAbstract</link>
            <description>Authors: Hahn R, Fuqua-Whitley D, Wethington H, Lowy J, Liberman A, Crosby A, Fullilove M, Johnson R, Moscicki E, Price L, Snyder SR, Tuma F, Cory S, Stone G, Mukhopadhaya K, Chattopadhyay S, Dahlberg L, , 
    Universal school-based programs to reduce or prevent violent behavior are delivered to all children in classrooms in a grade or in a school. Similarly, programs targeted to schools in high-risk areas (defined by low socioeconomic status or high crime rates) are delivered to all children in a grade or school in those high-risk areas. During 2004-2006, the Task Force on Community Preventive Services (Task Force) conducted a systematic review of published scientific evidence concerning the effectiveness of these programs. The results of this review provide strong evidence that universa...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=792183</comments>
            <pubDate>Fri, 10 Aug 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">792183</guid>        </item>
        <item>
            <title>Compendium of Measures to Prevent Disease Associated with Animals in Public Settings, 2007: National Association of State Public Health Veterinarians, Inc. (NASPHV).</title>
            <link>http://www.medworm.com/index.php?rid=732048&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17625497%26dopt%3DAbstract</link>
            <description>This report updates the 2006 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2006;55[No. RR-10]). The groups of persons for whom vaccination is recommended and the antiviral medications recommended for chemoprophylaxis or treatment (oseltamivir or zanamivir) have not changed. Estimated vaccination coverage remains &amp;lt;50% among certain groups for whom routine annual vaccination is recommended, including young children and adults with risk factors for influenza complications, health-care personnel (HCP), and pregnant women. Strategies to improve vaccination coverage, including use ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=732048</comments>
            <pubDate>Fri, 13 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">732048</guid>        </item>
        <item>
            <title>Compendium of measures to prevent disease associated with animals in public settings, 2007: National Association of State Public Health Veterinarians, Inc. (NASPHV).</title>
            <link>http://www.medworm.com/index.php?rid=719207&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17615524%26dopt%3DAbstract</link>
            <description>This report provides recommendations for public health officials, veterinarians, animal venue staff, animal exhibitors, visitors to animal venues, physicians, and others concerned with minimizing risks associated with animals in public settings. The recommendation to wash hands is the single most important prevention step for reducing the risk for disease transmission. Other critical recommendations are that venues not allow food in animal areas, venues include transition areas between animal areas and nonanimal areas, visitors be educated about disease risk and prevention procedures, and animals be properly cared for and managed.
    PMID: 17615524 [PubMed - in process] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=719207</comments>
            <pubDate>Fri, 06 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">719207</guid>        </item>
        <item>
            <title>Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=691714&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17585291%26dopt%3DAbstract</link>
            <description>This report revises, updates, and replaces the 1996 and 1999 ACIP statements for prevention of varicella. The new recommendations include 1) implementation of a routine 2-dose varicella vaccination program for children, with the first dose administered at age 12-15 months and the second dose at age 4-6 years; 2) a second dose catch-up varicella vaccination for children, adolescents, and adults who previously had received 1 dose; 3) routine vaccination of all healthy persons aged &amp;gt; or = 13 years without evidence of immunity; 4) prenatal assessment and postpartum vaccination; 5) expanding the use of the varicella vaccine for HIV-infected children with age-specific CD4+ T lymphocyte percentages of 15%-24% and adolescents and adults with CD4+ T lymphocyte counts &amp;gt; or = 200 cells/microL; ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=691714</comments>
            <pubDate>Fri, 22 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">691714</guid>        </item>
        <item>
            <title>Compendium of Animal Rabies Prevention and Control, 2007: National Association of State Public Health Veterinarians, Inc. (NASPHV).</title>
            <link>http://www.medworm.com/index.php?rid=525612&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17410084%26dopt%3DAbstract</link>
            <description>Authors:  , 
    Rabies is a fatal viral zoonosis and a serious public health problem. The disease is an acute progressive encephalitis caused by a lyssavirus. Multiple viral variants are maintained in wild mammal populations in the United States, but all mammals are believed to be susceptible to the disease. For purposes of this document, use of the term &quot;animal&quot; refers to mammals. The recommendations in this compendium serve as a basis for animal rabies-prevention and -control programs throughout the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an effective national rabies-control program. This document is reviewed annually and revised as necessary. These recommendations do not supersede state and local laws or requirements. Prin...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=525612</comments>
            <pubDate>Fri, 06 Apr 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">525612</guid>        </item>
        <item>
            <title>Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=498771&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17380109%26dopt%3DAbstract</link>
            <description>This report summarizes the epidemiology of HPV and associated diseases, describes the licensed HPV vaccine, and provides recommendations for its use for vaccination among females aged 9-26 years in the United States. Genital HPV is the most common sexually transmitted infection in the United States; an estimated 6.2 million persons are newly infected every year. Although the majority of infections cause no clinical symptoms and are self-limited, persistent infection with oncogenic types can cause cervical cancer in women. HPV infection also is the cause of genital warts and is associated with other anogenital cancers. Cervical cancer rates have decreased in the United States because of widespread use of Papanicolaou testing, which can detect precancerous lesions of the cervix before they d...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=498771</comments>
            <pubDate>Fri, 23 Mar 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">498771</guid>        </item>
        <item>
            <title>Indicators for occupational health surveillance.</title>
            <link>http://www.medworm.com/index.php?rid=361981&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17230144%26dopt%3DAbstract</link>
            <description>This report introduces the OHIs and describes CSTE's approach to developing this new occupational health surveillance tool.
    PMID: 17230144 [PubMed - in process] (Source: MMWR Recomm Rep)</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=361981</comments>
            <pubDate>Sun, 21 Jan 2007 04:30:02 +0100</pubDate>
            <guid isPermaLink="false">361981</guid>        </item>
        <item>
            <title>Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.</title>
            <link>http://www.medworm.com/index.php?rid=324575&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17167397%26dopt%3DAbstract</link>
            <description>Authors: Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV, , , 
    On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the United States for persons aged 11-64 years (ADACEL, manufactured by sanofi pasteur, Toronto, Ontario, Canada). Prelicensure studies demonstrated safety and efficacy, inferred through immunogenicity, against tetanus, diphtheria, and pertussis when Tdap was administered as a single booster dose to adults. To reduce pertussis morbidity among adults and maintain the standard of care for tetanus and diphtheria prevention and to reduce the transmission of pertussis to ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=324575</comments>
            <pubDate>Tue, 19 Dec 2006 10:18:02 +0100</pubDate>
            <guid isPermaLink="false">324575</guid>        </item>
        <item>
            <title>Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel.</title>
            <link>http://www.medworm.com/index.php?rid=321458&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17167397%26dopt%3DAbstract</link>
            <description>Authors: Kretsinger K, Broder KR, Cortese MM, Joyce PM, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV, 
    On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the United States for persons aged 11--64 years (ADACEL(R), manufactured by sanofi pasteur, Toronto, Ontario, Canada). Prelicensure studies demonstrated safety and efficacy, inferred through immunogenicity, against tetanus, diphtheria, and pertussis when Tdap was administered as a single booster dose to adults. To reduce pertussis morbidity among adults and maintain the standard of care for tetanus and diphtheria prevention and to reduce the transmission of pertussis to ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=321458</comments>
            <pubDate>Fri, 15 Dec 2006 21:00:02 +0100</pubDate>
            <guid isPermaLink="false">321458</guid>        </item>
        <item>
            <title>A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.</title>
            <link>http://www.medworm.com/index.php?rid=318338&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17159833%26dopt%3DAbstract</link>
            <description>This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection. The first part of the ACIP statement, which provided recommendations for immunization of infants, children, and adolescents, was published previously (CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices [ACIP]. Part 1: immunization of infants, children, and adolescents. MMWR 2005;54[No. RR-16]:1-33). In settings in which a high proportion of adults have risks for HBV infection (e.g., sexually transmitted disease/human immunodeficiency virus t...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=318338</comments>
            <pubDate>Thu, 14 Dec 2006 02:22:02 +0100</pubDate>
            <guid isPermaLink="false">318338</guid>        </item>
        <item>
            <title>General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=303627&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D17136024%26dopt%3DAbstract</link>
            <description>This report is a revision of General Recommendations on Immunization and updates the 2002 statement by the Advisory Committee on Immunization Practices (ACIP) (CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices and the American Academy of Family Physicians. MMWR 2002;51[No. RR-2]). This report is intended to serve as a general reference on vaccines and immunization. The principal changes include 1) expansion of the discussion of vaccination spacing and timing; 2) an increased emphasis on the importance of injection technique/age/body mass in determining appropriate needle length; 3) expansion of the discussion of storage and handling of vaccines, with a table defining the appropriate storage temperature range for inactivated an...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=303627</comments>
            <pubDate>Sun, 03 Dec 2006 08:49:02 +0100</pubDate>
            <guid isPermaLink="false">303627</guid>        </item>
        <item>
            <title>Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.</title>
            <link>http://www.medworm.com/index.php?rid=203190&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D16988643%26dopt%3DAbstract</link>
            <description>The objectives of these recommendations are to increase HIV screening of patients, including pregnant women, in health-care settings; foster earlier detection of HIV infection; identify and counsel persons with unrecognized HIV infection and link them to clinical and prevention services; and further reduce perinatal transmission of HIV in the United States. These revised recommendations update previous recommendations for HIV testing in health-care settings and for screening of pregnant women (CDC. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR 1993;42[No. RR-2]:1-10; CDC. Revised guidelines for HIV counseling, testing, and referral. MMWR 2001;50[No. RR-19]:1-62; and CDC. Revised recommendations for HIV screening of pregnant wo...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=203190</comments>
            <pubDate>Sun, 24 Sep 2006 00:11:02 +0100</pubDate>
            <guid isPermaLink="false">203190</guid>        </item>
        <item>
            <title>Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=184477&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D16960552%26dopt%3DAbstract</link>
            <description>This report describes the steps that should be taken to 1) investigate a case that might have been acquired locally, 2) prevent a small focus of malaria cases from becoming a source of sustained transmission, and 3) inform clinicians regarding the process of an investigation so they can effectively address concerns and questions from patients. Although these locally acquired mosquito-transmitted outbreaks frequently involve only a limited number of infected persons, they frequently raise concerns in the community and require substantial public health resources. For example, as a result of the most recent local outbreak of eight malaria cases in Florida in 2003, reverse 911 telephone calls (a community notification system) were made to approximately 300,000 residents; insect repellent, post...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=184477</comments>
            <pubDate>Fri, 08 Sep 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">184477</guid>        </item>
        <item>
            <title>Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=144504&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D16902398%26dopt%3DAbstract</link>
            <description>Authors: Parashar UD, Alexander JP, Glass RI, 
    In February 2006, a live, oral, human-bovine reassortant rotavirus vaccine (RotaTeq) was licensed for use among U.S. infants. The Advisory Committee on Immunization Practices recommends routine vaccination of U.S. infants with 3 doses of this rotavirus vaccine administered orally at ages 2, 4, and 6 months. The first dose should be administered between ages 6-12 weeks. Subsequent doses should be administered at 4-10 week intervals, and all 3 doses should be administered by age 32 weeks. Rotavirus vaccine can be co-administered with other childhood vaccines. Rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.
    PMID: 16902398 [PubMed - in process] (So...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=144504</comments>
            <pubDate>Fri, 11 Aug 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">144504</guid>        </item>
        <item>
            <title>Sexually transmitted diseases treatment guidelines, 2006.</title>
            <link>http://www.medworm.com/index.php?rid=137766&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D16888612%26dopt%3DAbstract</link>
            <description>Authors: Workowski KA, Berman SM
    These guidelines for the treatment of persons who have sexually transmitted diseases (STDs) were developed by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta, Georgia, during April 19-21, 2005. The information in this report updates the Sexually Transmitted Diseases Treatment Guidelines, 2002 (MMWR 2002;51[No. RR-6]). Included in these updated guidelines are an expanded diagnostic evaluation for cervicitis and trichomoniasis; new antimicrobial recommendations for trichomoniasis; additional data on the clinical efficacy of azithromycin for chlamydial infections in pregnancy; discussion of the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implicati...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=137766</comments>
            <pubDate>Fri, 04 Aug 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">137766</guid>        </item>
        <item>
            <title>Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).</title>
            <link>http://www.medworm.com/index.php?rid=126890&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D16874296%26dopt%3DAbstract</link>
            <description>This report updates the 2005 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2005;54[No. RR-8]:1--44). The 2006 recommendations include new and updated information. Principal changes include 1) recommending vaccination of children aged 24-59 months and their household contacts and out-of-home caregivers against influenza; 2) highlighting the importance of administering 2 doses of influenza vaccine for children aged 6 months--&amp;lt;9 years who were previously unvaccinated; 3) advising health-care providers, those planning organized campaigns, and state and local public health agencies ...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=126890</comments>
            <pubDate>Fri, 28 Jul 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">126890</guid>        </item>
        <item>
            <title>Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association.</title>
            <link>http://www.medworm.com/index.php?rid=112673&amp;cid=s_28383_54_f&amp;fid=28383&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D16826161%26dopt%3DAbstract</link>
            <description>This report provides a framework and general guidelines for effective prevention and control of TB in jails, prisons, and other correctional and detention facilities. Recommendations were developed on the basis of published guidelines and a review of the scientific literature. Effective TB-prevention and -control measures in correctional facilities include early identification of persons with TB disease through entry and periodic follow-up screening; successful treatment of TB disease and latent TB infection; appropriate use of airborne precautions (e.g., airborne infection isolation, environmental controls, and respiratory protection); comprehensive discharge planning; and thorough and efficient contact investigation. These measures should be instituted in close collaboration with local o...</description>
            <author>MMWR Recomm Rep</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=112673</comments>
            <pubDate>Fri, 07 Jul 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">112673</guid>        </item>
    </channel>
</rss>

